Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity or its related term are showing as below:
ISX:CARE'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -3.53 Med: -2.18 Max: 1.13
Current: 1.13
During the past 10 years, PT Metro Healthcare Indonesia Tbk's highest Return-on-Tangible-Equity was 1.13%. The lowest was -3.53%. And the median was -2.18%.
ISX:CARE's Return-on-Tangible-Equity is ranked worse than 72.24% of 580
companies
in the Healthcare Providers & Services industry
Industry Median: 10.085
vs ISX:CARE: 1.13
PT Metro Healthcare Indonesia Tbk (ISX:CARE) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Equity Related Terms
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Equity Chart
ISX:CARE vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Metro Healthcare Indonesia Tbk Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 0.02% mean?
PT Metro Healthcare Indonesia Tbk (ISX:CARE) has a Return-on-Tangible-Equity of 0.02% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. According to the industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #419 out of 580 companies in the Healthcare Providers & Services industry, placing it in the top 72.2%.
Is PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity too high?
PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Equity is 0.02%. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.09. PT Metro Healthcare Indonesia Tbk's value of 0.02% is 99.8% below this industry median. Based on the distribution chart, PT Metro Healthcare Indonesia Tbk ranks #419 out of 580 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, PT Metro Healthcare Indonesia Tbk has a GF Score™ of 77/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PT Metro Healthcare Indonesia Tbk's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Metro Healthcare Indonesia Tbk ranks #419 out of 580 companies for Return-on-Tangible-Equity. This places PT Metro Healthcare Indonesia Tbk in the lower half of its industry. The industry median Return-on-Tangible-Equity is 10.09. PT Metro Healthcare Indonesia Tbk's value of 0.02% is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.09, based on 580 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Equity of 0.02% is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on PT Metro Healthcare Indonesia Tbk and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Metro Healthcare Indonesia Tbk's current Return-on-Tangible-Equity is 0.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Metro Healthcare Indonesia Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk (ISX:CARE) is currently considered Modestly Overvalued. The stock's GF Value™ is Rp368.55, compared to a current price of Rp426.00 — trading 15.6% above its estimated fair value. The current Return-on-Tangible-Equity is 0.02% and 99.8% below the Healthcare Providers & Services industry median of 10.09. PT Metro Healthcare Indonesia Tbk's overall GF Score™ is 77/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For PT Metro Healthcare Indonesia Tbk (ISX:CARE), the current Return-on-Tangible-Equity is 0.02% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Metro Healthcare Indonesia Tbk (ISX:CARE) Overvalued in 2026?
Based on GuruFocus' analysis, PT Metro Healthcare Indonesia Tbk stock appears to be overvalued.
The current stock price of Rp426.00 is trading 15.6% above its estimated GF Value™ of Rp368.55.
GuruFocus considers PT Metro Healthcare Indonesia Tbk to be Modestly Overvalued.
Key valuation signals for ISX:CARE:
Return-on-Tangible-Equity: 0.02%
GF Value™: Rp368.55 vs. price of Rp426.00 (15.6% above fair value)
Industry Position: 99.8% below the Healthcare Providers & Services median (#419 of 580)
No single metric tells the full story. See the ISX:CARE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Metro Healthcare Indonesia Tbk Business Description
PT Metro Healthcare Indonesia Tbk provides integrated health services that consist of hospital and technology-based health services and training centers to produce professionals in health services. The company manages hospitals that are members of the Metro Hospital Group. Its business segment comprises Hospital services and Investment. The majority of revenue is derived from the Hospital services segment that comprises integrated healthcare services for inpatient and outpatient.
77GF Score
Get the complete analysis for ISX:CARE
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:CARE has been successfully added to your 
